华兰生物2023年限制性股票激励计划部分股票回购注销完成公告（2026年）

华兰生物工程股份有限公司部分限制性股票回购注销完成公告详细解析

一、公告核心内容

华兰生物工程股份有限公司（以下简称“公司”）已完成对部分限制性股票的回购注销手续。
本次涉及83名激励对象，回购注销股票数量为1,765,680股，占公司回购注销前总股本的0.0966%。
回购注销价格为每股9.89元，总金额为17,462,575.20元，资金来源为公司自有资金。
注销完成后，公司总股本由1,827,456,666股减少至1,825,690,986股。
公司已收到中国证券登记结算有限责任公司深圳分公司出具的《证券过户登记确认书》，后续将依法办理工商变更登记手续。

二、回购注销背景与原因

本次回购注销源于公司2023年限制性股票激励计划业绩考核未达标。2025年度业绩未达到激励计划规定的触发值和目标值。
根据大华会计师事务所出具的审计报告，公司2025年度归属于上市公司股东的扣非后净利润为92,003.81万元，未达业绩增长目标（90%增长率，目标值72%增长率）。因此，对已授但未解除限售的限制性股票进行回购注销。
业绩考核的安排为：2023年净利润较2022年增长30%（触发值24%），2024年增长50%（触发值40%），2025年增长90%（触发值72%）。

三、回购注销流程与价格调整

限制性股票回购价格受到公司派息调整，具体计算为：原价10.89元/股，扣除2023年、2024年、2025年派发现金红利共计1元/股，调整后回购价格为9.89元/股。
公司未发生资本公积转增股本、派送股票红利等事项，回购数量保持不变。
验资报告显示，公司已支付回购款，减少股本及资本公积。

四、股本结构变动

本次回购注销后，公司有限售条件流通股数量由253,913,612股变为252,147,932股，比例由13.89%降至13.81%。
股权激励锁定股由1,765,680股降至0股（清零）。
无限售条件流通股保持不变，为1,573,543,054股，占比提升至86.19%。
公司控股股东及实际控制人未发生变化，股权分布仍具备上市条件。

五、对公司业绩和股价的影响

本次回购注销及回购价格调整不会对公司财务状况和经营成果产生实质性影响。
不会影响公司管理团队的勤勉尽职，亦不会损害公司利益。
公司管理团队将继续认真履行职责，为股东创造价值。
本次公告反映公司未达激励业绩目标，部分未解锁股票回购注销，显示公司业绩压力。
对于投资者而言，若公司无法持续达标激励计划业绩目标，可能影响市场对公司未来业绩增长的预期，具有一定的价格敏感性。

六、备查文件

验资报告
注销股份明细表

七、投资者关注要点

业绩未达标导致部分限制性股票回购注销，显示公司经营压力。
股本结构发生微调，股权激励锁定股已清零。
此类回购注销行为虽不会对公司业绩产生实质影响，但反映公司激励机制与业绩表现的联动，对投资者未来预期有一定参考价值。
公司管理层承诺继续勤勉尽职，积极创造价值。

免责声明

本文章仅供投资者参考，不构成任何投资建议。投资者请结合自身情况及风险偏好，审慎决策。市场有风险，投资需谨慎。

English Version

Detailed Analysis: Completion of Restricted Stock Buyback and Cancellation by Hualan Biological Engineering Co., Ltd.

1. Key Points

Hualan Biological Engineering Co., Ltd. has completed the buyback and cancellation of a portion of restricted shares.
This action involves 83 incentive recipients, with 1,765,680 shares bought back and cancelled, accounting for 0.0966% of the pre-cancellation total share capital.
The buyback price was RMB 9.89 per share, totaling RMB 17,462,575.20, funded by company’s own capital.
After cancellation, total share capital decreased from 1,827,456,666 shares to 1,825,690,986 shares.
The company has received confirmation from China Securities Depository and Clearing Corporation (Shenzhen), and will proceed with business registration change procedures.

2. Background and Reason for Buyback

This buyback stems from the company’s 2023 restricted stock incentive plan failing to meet performance targets for 2025.
According to the audit report by Da Hua CPA, net profit attributable to shareholders for 2025 was RMB 920.0381 million, failing to meet the target trigger value and target value (90% growth, trigger value 72%).
Performance assessment: 2023 net profit vs. 2022 (30% target, 24% trigger), 2024 (50% target, 40% trigger), 2025 (90% target, 72% trigger).

3. Buyback Process and Price Adjustment

Buyback price adjusted for company dividend payouts: original price RMB 10.89/share minus total dividend RMB 1/share, resulting in adjusted price RMB 9.89/share.
No change in buyback quantity, as no share splits, bonus shares, or capital increases occurred.
Verification report confirms payment and capital reduction.

4. Share Structure Change

After buyback, restricted tradable shares decreased from 253,913,612 to 252,147,932 shares (13.89% to 13.81%).
Incentive lock-up shares now zero.
Unrestricted tradable shares remain at 1,573,543,054 shares (increased proportion to 86.19%).
No change in controlling shareholders or actual controllers; shareholding remains compliant for listing.

5. Impact on Performance and Share Price

This buyback and price adjustment will not materially affect the company’s financial status or operating results.
Management remains diligent; no harm to company interests.
Completion of buyback reflects pressure on company performance, as incentive plan targets were not met.
For investors, repeated failure to meet incentive plan targets may affect expectations for future growth, making this news price sensitive.

6. Reference Documents

Verification Report
Details of Cancelled Shares

7. Investor Focus

Performance miss led to restricted share buyback and cancellation, signaling pressure on company operations.
Share structure adjusted; incentive lock-up shares now zero.
Such buybacks, though not impacting performance directly, reflect the link between incentive mechanisms and company performance, relevant for investors’ future expectations.
Management promises ongoing diligence and value creation for shareholders.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Please make prudent decisions based on your own situation and risk tolerance. Investing comes with risks; please be cautious.